GT Biopharma, Inc. (the "Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
North Korean authorities have launched another so-called mopping-up operation—a sweeping crackdown—on users of Chinese mobile ...
If a recent update from journalist Mark Hendry in his Substack column (as posted in X) is believed to be true, Celtic are ...
The public catering management office in Kaechon, South Pyongan province, has begun replacing many vendors at soft drink ...
The Croatian striker’s mentor Senijad Ibricic believes the world is his oyster as top five league future is mapped out ...
Bugatti niyo kompanyi y'imodoka iherutse kwinjira mu kubaka 'apartments' z'agatangaza zigenewe abakire cyane, nka Neymar ...
Brut America on MSNOpinion
P!nk opened up about how she integrates feminism and fighting for women's rights into her career
Iran's collapse or survival hinges on one choice inside the Revolutionary Guard Archaeologists thought they found wires ...
Chelsea and David Datro Fofana are working on a permanent exit this window, with Celtic, Royal Antwerp and Derby County all ...
GT Biopharma submitted an IND application for GTB-5550 TriKE for solid tumors. Phase 1 trial planned for 2026.
Chelsea are keen to capitalise on that form by offloading the frontman permanently to free up and international loan slot.
President Lee Jae Myung and Japanese Prime Minister Sanae Takaichi on Tuesday emphasized the importance of South Korea–Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback